COPENHAGEN, June 24 (Reuters) - Danish drugmaker Novo

Nordisk will launch its weight-loss drug Wegovy in

India without any supply constraints, a company spokesperson

said on Tuesday.

"We are committed to addressing the unmet needs of patients

living with chronic diseases such as obesity, thus this will be

a full launch," the spokesperson said in an emailed statement.

"We do not anticipate any supply constraints and are

confident of stable supply of the product in India."